Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Goodwill & Intangibles (2016 - 2025)

Nutex Health's Goodwill & Intangibles history spans 14 years, with the latest figure at $13.9 million for Q3 2025.

  • For Q3 2025, Goodwill & Intangibles changed N/A year-over-year to $13.9 million; the TTM value through Sep 2025 reached $13.9 million, changed N/A, while the annual FY2024 figure was $29.4 million, 26.98% down from the prior year.
  • Goodwill & Intangibles for Q3 2025 was $13.9 million at Nutex Health, down from $15.2 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $447.7 million in Q2 2022 and bottomed at $1.8 million in Q4 2021.
  • The 5-year median for Goodwill & Intangibles is $23.7 million (2023), against an average of $56.0 million.
  • The largest annual shift saw Goodwill & Intangibles skyrocketed 3636.2% in 2021 before it crashed 96.2% in 2023.
  • A 5-year view of Goodwill & Intangibles shows it stood at $1.8 million in 2021, then soared by 2060.4% to $39.4 million in 2022, then rose by 2.46% to $40.3 million in 2023, then decreased by 26.98% to $29.4 million in 2024, then plummeted by 52.74% to $13.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Goodwill & Intangibles are $13.9 million (Q3 2025), $15.2 million (Q1 2025), and $29.4 million (Q4 2024).